Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Medicago Inc MDCGF

GREY:MDCGF - Post Discussion

Medicago Inc > 10 mill doses/month = HUGE profits
View:
Post by Indicator on Mar 23, 2011 1:12pm

10 mill doses/month = HUGE profits

So all in, if memory serves, I believe that MDG's costs per dose are in the pennies, while the 2009 H5N1 vaccine estimated sale price, according to the WHO, is $3.00 per dose.

https://www.who.int/csr/disease/influenza/H5N1_Stockpile_Design_Feb2009.pdf


For other vaccines such as Influenza vaccine, according to CDC's link below,
per dose prices are in the $7 to $20 range!


Here's my conservative, rough calculations for the cheaper H5N1 vaccine:
One 90,000 sq ft facility producing 10 million doses/month
10 million doses X $3.00 = $30 Million gross revenue / month.
THIS DOES NOT INCLUDE the capacity to RAMP UP more vaccine production as they have stated!

Then after this US plant gets rolling, we have a French plant in the works, and then the Arab MOE with another possible plant, and then India .... and then .... MASSIVE profits AHEAD!


FYI - Here is a price list:
https://www.cdc.gov/vaccines/programs/vfc/cdc-vac-price-list.htm#adflu
Comment by dades216 on Mar 24, 2011 11:28am
Your model assumes that capacity = production. I am new with this company and I have been reviewing news releases. My understanding is that the agreement between the US and the Company is about capacity and no engagement for sales exists. Correct?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities